Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) PB Ratio: 0.95 (As of Jul. 12, 2026) — 21% Below Median


TPE:1762 Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
58 GF Score
Price NT$38.15
GF Value NT$37.92
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Chunghwa Chemical Synthesis & Biotech Co PB Ratio?

Chunghwa Chemical Synthesis & Biotech Co TPE:1762 58 PB Ratio is 0.95 as of Jul. 12, 2026, which is 21% below its 10-year median of 1.21. GuruFocus rates TPE:1762 with a GF Score™ of 58/100 and a GF Value™ of NT$37.92 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,231 Biotechnology companies, Chunghwa Chemical Synthesis & Biotech Co ranks better than 84.16% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-12), Chunghwa Chemical Synthesis & Biotech Co's share price is NT$38.15. Chunghwa Chemical Synthesis & Biotech Co's Book Value per Share for the quarter that ended in Dec. 2025 was NT$40.14. Hence, Chunghwa Chemical Synthesis & Biotech Co's PB Ratio of today is 0.95.

Warning Sign:

Chunghwa Chemical Synthesis & Biotech Co Ltd stock PB Ratio (=0.95) is close to 1-year high of 1.05.

The historical rank and industry rank for Chunghwa Chemical Synthesis & Biotech Co's PB Ratio or its related term are showing as below:

TPE:1762' s PB Ratio Range Over the Past 10 Years
Min: 0.58   Med: 1.21   Max: 2.48
Current: 0.95

During the past 13 years, Chunghwa Chemical Synthesis & Biotech Co's highest PB Ratio was 2.48. The lowest was 0.58. And the median was 1.21.

TPE:1762's PB Ratio is ranked better than
84.16% of 1231 companies
in the Biotechnology industry
Industry Median: 2.93 vs TPE:1762: 0.95

During the past 12 months, Chunghwa Chemical Synthesis & Biotech Co's average Book Value Per Share Growth Rate was -7.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -0.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 4.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 7.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Chunghwa Chemical Synthesis & Biotech Co was 16.60% per year. The lowest was -0.80% per year. And the median was 4.70% per year.

Back to Basics: PB Ratio


Chunghwa Chemical Synthesis & Biotech Co  (TPE:1762) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Chunghwa Chemical Synthesis & Biotech Co PB Ratio Related Terms


Chunghwa Chemical Synthesis & Biotech Co PB Ratio Historical Data

* Premium members only.

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chunghwa Chemical Synthesis & Biotech Co PB Ratio Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.74 1.59 1.33 0.78 0.61

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.70 0.61 0.62 0.61

TPE:1762 vs VRTX, REGN, ALNY: PB Ratio Comparison

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chunghwa Chemical Synthesis & Biotech Co PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's PB Ratio falls into.


TPE:1762
58GF Score
Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chunghwa Chemical Synthesis & Biotech Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Chunghwa Chemical Synthesis & Biotech Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=38.15/40.138
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 0.95 mean?
Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) has a PB Ratio of 0.95 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors. This is 21% below median its historical median of 1.21. Over the past decade, Chunghwa Chemical Synthesis & Biotech Co's PB Ratio has ranged from 0.58 to 2.48. According to the industry distribution chart, Chunghwa Chemical Synthesis & Biotech Co ranks #195 out of 1231 companies in the Biotechnology industry, placing it in the top 15.8%.
Is Chunghwa Chemical Synthesis & Biotech Co's PB Ratio too high?
Chunghwa Chemical Synthesis & Biotech Co's current PB Ratio of 0.95 is 21% below median its 10-year median of 1.21. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 2.48. The Biotechnology industry median PB Ratio is 2.93. Chunghwa Chemical Synthesis & Biotech Co's value of 0.95 is 67.6% below this industry median. Based on the distribution chart, Chunghwa Chemical Synthesis & Biotech Co ranks #195 out of 1231 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Chunghwa Chemical Synthesis & Biotech Co has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chunghwa Chemical Synthesis & Biotech Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chunghwa Chemical Synthesis & Biotech Co ranks #195 out of 1231 companies for PB Ratio. This places Chunghwa Chemical Synthesis & Biotech Co in the top 16% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.93. Chunghwa Chemical Synthesis & Biotech Co's value of 0.95 is 67.6% below this benchmark. Historically, Chunghwa Chemical Synthesis & Biotech Co's own PB Ratio has ranged from 0.58 to 2.48 over the past decade. While the company's 10-year median is 1.21 vs. the industry median of 2.93, Chunghwa Chemical Synthesis & Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.93, based on 1,231 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chunghwa Chemical Synthesis & Biotech Co's current PB Ratio of 0.95 is 67.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chunghwa Chemical Synthesis & Biotech Co's current PB Ratio is 0.95, which is 21% below median its own 10-year median of 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chunghwa Chemical Synthesis & Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) is currently considered Fairly Valued. The stock's GF Value™ is NT$37.92, compared to a current price of NT$38.15 — trading 0.6% above its estimated fair value. The current PB Ratio is 0.95, which is 21% below median its 10-year median of 1.21 and 67.6% below the Biotechnology industry median of 2.93. Chunghwa Chemical Synthesis & Biotech Co's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Chunghwa Chemical Synthesis & Biotech Co (TPE:1762), the current PB Ratio is 0.95 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Overvalued in 2026?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co stock appears to be overvalued. The current stock price of NT$38.15 is trading 0.6% above its estimated GF Value™ of NT$37.92. GuruFocus considers Chunghwa Chemical Synthesis & Biotech Co to be Fairly Valued.

Key valuation signals for TPE:1762:

  • PB Ratio: 0.95 (21% below median its 10-year median of 1.21)
  • GF Value™: NT$37.92 vs. price of NT$38.15 (0.6% above fair value)
  • GF Score™: 58/100 with 8 warning signs
  • Industry Position: 67.6% below the Biotechnology median (#195 of 1231)

No single metric tells the full story. See the TPE:1762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Address No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.
58GF Score

Get the complete analysis for TPE:1762

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.15
Price
NT$37.92
GF Value